Table 3 Association between each selected gene expression with immunophenotypic markers and laboratory findings n = 52).
n (52) | CREBBP (p-value) | CEBPA (p-value) | DNMT3A (p-value) | ||
|---|---|---|---|---|---|
HLA-DR | Present | 27 | 0.729 | 0.288 | 0.264 |
Absent | 25 | ||||
CD117 | Present | 19 | 0.729 | 0.549 | 0.028* |
Absent | 33 | ||||
CD11c | Present | 8 | 0.642 | 0.833 | 0.462 |
Absent | 44 | ||||
CD34 | Present | 19 | 0.467 | 0.305 | 0.524 |
Absent | 33 | ||||
CD7 | Present | 5 | 1.00 | 0.449 | 0.526 |
Absent | 47 | ||||
CD4 | Present | 8 | 0.642 | 0.501 | 0.630 |
Absent | 44 | ||||
CD14 | Present | 11 | 0.424 | 1.00 | 0.991 |
Absent | 41 | ||||
TLC count | Median (Range) 22 (0.5-266.32) | 0.017* | 0.340 | 0.822 | |
Hb level | Median (Range) 7.7 (2.3–10.3) | 0.973 | 0.143 | 0.258 | |
PLT count | Median (Range) 26 (3-137) | 0.306 | 0.660 | 0.697 | |
Blast count | Median (Range) 60 (21–97) | 0.341 | 0.670 | 0.557 | |
